|
|
||||||
 | ||||||
|
|
CyberKnife targets tumors, brings new hopeHow it works | What to expect | Information for physicians | Our team John Gardetto believed in helping people, in his work and his philanthropy.
The former president of Gardetto's Bakery died at age 71 in June 2007. Before his passing, he left a legacy of kindness that will long be remembered. Part of that legacy was to help bring an innovative treatment, called the CyberKnife, to Wisconsin. It is a technology that precisely targets tumors with high-energy radiation. A longtime supporter of Aurora St. Luke's Medical Center, John was enthusiastic when he heard the hospital was exploring the technology. Little did he know he would be among those to receive this unique treatment. Judy Gardetto said her husband was a pioneer who was concerned about others. “He used to say to me, ‘If our employees do well, we'll do well.' And that's why he wanted to make a gift toward the CyberKnife – he thought he might be able to help someone else.” And he has. Kenneth Bastin, MD, clinical director of radiation oncology at Aurora St. Luke's and director of CyberKnife radiosurgery, said: “Without question, we have patients who today are alive because of this amazing technology. Robotic radiosurgery with the CyberKnife allows us to treat people without incisions or anesthetic. It delivers a very intense dose of cancer-killing radiation with minimal side effects in an outpatient setting.”
|
||||
 |
||||||
 |
 |
 |
|
 |
||
